Clinical benefit and residual kidney function of en bloc nephrectomy for perirenal retroperitoneal sarcoma

Chan Woo Cho, Kyo Won Lee, Hyojun Park, Hyung Joon Kim, Jae Berm Park, Yoon La Choi, Jeong Il Yu, Su Jin Lee, Dong Il Choi, Sung Joo Kim

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Aim: The purpose of this study was to evaluate the efficacy of en bloc nephrectomy for perirenal retroperitoneal sarcoma (RPS) with respect to postoperative kidney function and oncological benefits. Methods: We performed a comparative study of 114 patients undergoing surgery for primary RPS, classifying cases as nephrectomy (NPX, n = 65) versus no nephrectomy (no-NPX, n = 49). The Δ and % change between preoperative and postoperative estimated glomerulus filtration rate (eGFR) were analyzed to compare renal function changes after surgery. Kaplan–Meier analysis was performed to verify the incidence of local relapse between the two groups. Results: During a median follow-up of 29 months, median postoperative GFR of 65 patients in the NPX group decreased to 73.5% of preoperative eGFR. Although 38 patients (58%) in the NPX group experienced a progression in chronic kidney disease stage after nephrectomy, no patients progressed to end-stage renal disease (ESRD). In French Federation of Cancer Centers Sarcoma grade 2, the NPX group had statistically significant local control benefits, compared with the no-NPX group (P = 0.048). Conclusions: Residual renal function after en bloc nephrectomy was stabilized without progression to ESRD. Moreover, en bloc nephrectomy for perirenal RPS might secure a complete resection margin for local tumor control.

Original languageEnglish
Pages (from-to)e465-e471
JournalAsia-Pacific Journal of Clinical Oncology
Issue number5
StatePublished - Oct 2018

Bibliographical note

Funding Information:
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1A6A3A11935392).

Publisher Copyright:
© 2017 The Authors. Asia-Pacific Journal of Clinical Oncology Published by John Wiley & Sons Australia, Ltd.


  • en bloc nephrectomy
  • local tumor control
  • residual kidney function
  • retroperitoneal sarcoma


Dive into the research topics of 'Clinical benefit and residual kidney function of en bloc nephrectomy for perirenal retroperitoneal sarcoma'. Together they form a unique fingerprint.

Cite this